Mapping large numbers of results may take a few moments.
Search Results
Showing 201 - 250 of 330 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Midnight Pharma LLC | Activity: Research and Development | Company Description Midnight Pharma is developing a treatment for insomnia. | Location Morrisville |
| |
Company Milestone Pharmaceuticals USA Inc. | Activity: Research and Development | Company Description Milestone Pharmaceuticals is developing an investigational new drug intended to provide rapid-onset and short-acting treatment of paroxysmal supraventricular tachycardia (PSVT) episodes and other episodic conditions. | Location Charlotte |
| |
Company Mind Medicine Inc. | Activity: Research and Development | Company Description Mind Medicine is a clinical-stage biopharmaceutical company developing products using the therapeutic potential of psychedelics to treat brain health disorders, with a focus on psychiatry, addiction, pain and neurology. | Location Durham |
| |
Company Mizar Therapeutics | Activity: Research and Development | Company Description Mizar Therapeutics is a platform therapeutics company that provides drug discovery services using proprietary live-cell single-molecule imaging and machine-learning technology. | Location Chapel Hill |
| |
Company ML Bio Solutions Inc. | Activity: Research and Development | Company Description ML Bio Solutions is developing an oral treatment for patients with limb girdle muscular dystrophy 2i. | Location Charlotte |
| |
Company MonomerChem Inc. | Activity: Contract Research and Testing | Company Description MonomerChem provides contract drug development services, including custom synthesis, medicinal chemistry, lead optimization and synthesis of reference standards and metabolites. | Location Durham |
| |
Company Mucommune LLC | Activity: Research and Development | Company Description Mucommune is developing a platform using monoclonal antibodies and mucus to reinforce the mucus barrier for female reproductive health. | Location Durham |
| |
Company Mycovia Pharmaceuticals Inc. | Activity: Research and Development | Company Description Mycovia Pharmaceuticals is developing therapies to treat yeast and fungal infections. | Location Durham |
| |
Company NabGen Inc. | Activity: Research and Development | Company Description NabGen has developed a universal antibody suppressant technology to inhibit anti-drug and autoimmune antibodies, including suppression of pre-existing immunity and re-administration barriers to gene therapies based on adeno-associated virus (AAV) vectors. | Location Durham |
| |
Company Nelum Corp. | Activity: Research and Development | Company Description Nelum is a clinical-stage biopharmaceutical company developing patented drugs through an in-license process. Nelum´s focus is in oncology and fibrotic indications. | Location Cary |
| |
Company NeuroGT Inc. | Activity: Research and Development | Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. | Location Chapel Hill |
| |
Company Nicox Ophthalmics | Activity: Research and Development | Company Description Nicox Ophthalmics develops therapeutics from a proprietary nitric-oxide research platform to help maintain vision and improve ocular health. | Location Durham |
| |
Company NIOX Group | Activity: Sales and Operations | Company Description NIOX is a diagnostics and management company focused on improving asthma diagnosis and management. | Location Morrisville |
| |
Company Nova Thin Film Pharmaceuticals LLC | Activity: Research and Development | Company Description Nova Thin Film Pharmaceuticals develops and manufactures dissolving thin film using patented DepoFilm technology to solve drug delivery challenges. | Location Greensboro |
| |
Company NovaCyte LLC | Activity: Research and Development | Company Description NovaCyte isolates cells from donor corneas to grow replacement corneal tissue on a scaffold as a bioengineered equivalent to the current standard of care. | Location Winston-Salem |
| |
Company Novartis Gene Therapies | Activity: Production and Manufacturing | Company Description Novartis Gene Therapies develops and commercializes gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The Durham site is Novartis Gene Therapies' manufacturing operations. | Location Durham |
| |
Company Novex Innovations LLC | Activity: Production and Manufacturing | Company Description Novex Innovations is a contract development and manufacturing organization (CDMO) supporting large, medium, small and startup life science companies in the development of their products, from concept through manufacturing and commercialization. | Location Winston-Salem |
| |
Company Novo Nordisk Pharmaceutical Industries LP (API facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Active Pharmaceutical Ingredient (API) facility produces the API for an oral diabetes treatment through fermentation, purification and recovery processes. | Location Clayton |
| |
Company Novo Nordisk Pharmaceutical Industries LP (Durham) | Activity: Production and Manufacturing | Company Description Novo Nordisk manufactures tablets for an oral GLP-1 treatment for type 2 diabetes. | Location Durham |
| |
Company Novo Nordisk Pharmaceutical Industries LP (IFP facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Clayton facility manufactures insulin, GLP-1 products and prefilled delivery devices for the treatment of diabetes. | Location Clayton |
| |
Company NuRevelation LLC | Activity: Research and Development | Company Description NuRevelation develops drug delivery methods for pharmaceuticals, nutraceuticals and cannabinoids. | Location Durham |
| |
Company Ocaro Pharmaceuticals | Activity: Research and Development | Company Description Ocaro Pharmaceuticals develops opioid-sparing pain medications. | Location Greensboro |
| |
Company OmniAb Inc. (Durham) | Activity: Contract Research and Testing | Company Description OmniAb provides therapeutic antibody discovery technologies and antigen design. | Location Durham |
| |
Company On.Target Molecules Biotech Inc. | Activity: Research and Development | Company Description O.TM Biotech is developing anti-cancer monoclonal antibodies using a novel technology platform to accelerate advancements in cancer therapeutics. | Location Wilmington |
| |
Company OncoTAb Inc. | Activity: Research and Development | Company Description OncoTAb develops a continuum of products from early detection to treatment of epithelial cancers. Current products on the market and under development address unmet needs in the detection and treatment of pancreatic cancer as well as triple negative and metastatic breast cancer. | Location Charlotte |
| |
Company Oncurie Inc. | Activity: Research and Development | Company Description Oncurie is developing a cure for metastatic cancer through the use of novel molecular radionuclide technology. | Location Raleigh |
| |
Company Opus Genetics Inc. | Activity: Research and Development | Company Description Opus Genetics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases. | Location Research Triangle Park |
| |
Company Ortho Dermatologics, a division of Bausch Health | Activity: Sales and Operations | Company Description Ortho Dermatologics manages and markets Bausch Health's prescription dermatology portfolio, which includes acne, anti-fungal and anti-infective products. | Location Raleigh |
| |
Company Osmotica Pharmaceutical Corp. | Activity: Research and Development | Company Description Osmotica Pharmaceutical specializes in drug-delivery technologies and neurology-based therapies, including a treatment for Parkinson's disease. | Location Wilmington |
| |
Company Parion Sciences Inc. | Activity: Research and Development | Company Description Parion Sciences develops therapies to treat defects of the innate mucosal defense system in respiratory diseases. | Location Durham |
| |
Company Pathalys Pharma Inc. | Activity: Research and Development | Company Description Pathalys Pharma develops therapeutics that address unmet needs in the management of end stage kidney disesase (ESKD). | Location Raleigh |
| |
Company Pathfinder Pharmaceuticals Inc. | Activity: Research and Development | Company Description Pathfinder Pharmaceuticals specializes in early stage drug discovery with a focus on cancer therapy. | Location Durham |
| |
Company PETNET Solutions Inc. (Winston-Salem) | Activity: Production and Manufacturing | Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. | Location Winston-Salem |
| |
Company PETNET Solutions Inc., A Siemens Healthineers Company (Durham) | Activity: Production and Manufacturing | Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. | Location Durham |
| |
Company Pfizer Inc. (Durham) | Activity: Research and Development | Company Description Pfizer develops gene therapies to treat rare genetic central nervous system (CNS) and neuromuscular diseases. Pfizer's BioTherapeutics Pharmaceutical Sciences site in Durham houses clinical manufacturing space and analytical research development laboratories. | Location Durham |
| |
Company Pfizer Inc. (Rocky Mount) | Activity: Production and Manufacturing | Company Description Pfizer's Rocky Mount facility manufactures injectable hospital products. The facility also provides contract manufacturing services such as aseptic filling, lyophilization and terminal sterilization. | Location Rocky Mount |
| |
Company Pfizer Inc. (Sanford) | Activity: Production and Manufacturing | Company Description Pfizer's Sanford facility manufactures clinical trial and commercial materials for conjugate vaccines and gene therapies. | Location Sanford |
| |
Company Pfizer Sanford North | Activity: Production and Manufacturing | Company Description Pfizer Sanford North, formerly Abzena, is a CDMO producing cell-based biologics for academic research labs and pharmaceutical companies. The NC site makes mammalian biologics for customers involved in Phase 3 clinical trials and those already involved in commercial sales. | Location Sanford |
| |
Company Pharmgate Animal Health LLC | Activity: Research and Development | Company Description Pharmgate Animal Health develops and markets medicines and vaccines for the control of disease in livestock and poultry in North America. | Location Wilmington |
| |
Company Phenom Pharmaceuticals LLC | Activity: Research and Development | Company Description Phenom Pharmaceuticals develops preventatives and therapeutics. | Location Charlotte |
| |
Company PhosphoGam Inc. | Activity: Research and Development | Company Description PhosphoGam is developing allogeneic cell immunotherapies using gamma/delta T-cells to treat a variety of cancers. | Location Durham |
| |
Company Pinnacle Hill LLC | Activity: Research and Development | Company Description Pinnacle Hill, a joint venture of UNC-Chapel Hill and Deerfield Management, works with faculty to accelerate the development of their research projects to discover and develop new drugs and therapies for unmet needs. | Location Chapel Hill |
| |
Company Plakous Therapeutics Inc. | Activity: Research and Development | Company Description Plakous Therapeutics developed a cell-free placenta extract to prevent necrotizing enterocolitis in premature babies. The cytokines and growth factors purified in the product have anti-inflammatory, regenerative, and immunomodulatory properties analogous to mid-pregnancy amniotic fluid. | Location Winston-Salem |
| |
Company Praetego Inc. | Activity: Research and Development | Company Description Praetego is preclinical stage pharmaceutical company committed to improving health outcomes by addressing chronic diseases of aging, starting with Alzheimer’s Disease. Praetego’s novel small molecules inhibit a systemic driver of oxidative stress at the initiation of pathology. | Location Research Triangle Park |
| |
Company Precise Bio Inc. | Activity: Research and Development | Company Description Precise Bio grows live and vital complicated organs for transplant using 3D bio-printing. | Location Winston-Salem |
| |
Company Precision BioSciences Inc. (Durham) | Activity: Research and Development | Company Description Precision BioSciences is a clinical stage in vivo gene editing company using its novel ARCUS genome editing platform to develop new treatment options for genetic and infectious diseases. | Location Durham |
| |
Company Precision Biosciences Manufacturing Center for Advanced Therapeutics (RTP) | Activity: Production and Manufacturing | Company Description Precision BioSciences is a clinical stage in vivo gene editing company using its novel ARCUS genome editing platform to develop new treatment options for genetic and infectious diseases. | Location Research Triangle Park |
| |
Company Prinston Laboratories | Activity: Production and Manufacturing | Company Description Prinston Laboratories manufactures generic pharmaceuticals. | Location Charlotte |
| |
Company Priovant Therapeutics | Activity: Research and Development | Company Description Priovant is developing and commercializing targeted therapeutics for patients with severe autoimmune disease. | Location Durham |
| |
Company Procter & Gamble (Greensboro) | Activity: Production and Manufacturing | Company Description Procter & Gamble manufactures Vicks and other over-the-counter products. | Location Greensboro |